Literature DB >> 2502489

Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis.

F Maluenda1, A Csendes, P Burdiles, J Diaz.   

Abstract

Acute suppurative cholangitis is a serious complication in extrahepatic biliary tract obstruction. Bacteriological studies have shown that in these patients the bile cultures usually present several kinds of bacteria, especially Gram-negative aerobic bacteria such as E. coli and Klebsiella sp. The mortality rate in our patients with common bile duct stones and acute suppurative cholangitis is enhanced 5- to 10-fold. The aim of the present study was to analyse the bacterial properties of choledochal bile in a large number of patients with common bile duct stones, with or without acute suppurative cholangitis, and to determine the sensitivity of the isolated bacteria to several antibiotics used in clinical practice. The greatest sensitivity of the bacteria isolated from the common bile duct was seen for aminoglycosides (gentamicin and amikacin) and for cephalosporins, especially of the third generation (cefotaxime, ceftazidime, ceftriaxone and cefoperazone). Ampicillin showed a low sensitivity rate. The appropriate selection of the antibiotics used in acute suppurative cholangitis depends not only on the concentration of the antibiotic in the bile; a high plasma concentration is even more important to control the septic manifestations. A high excretion to the bile can affect the intestinal flora, leading to diarrhea (e. g. with cefoperazone). Ampicillin has been giving contradictory results in respect of bile and plasma concentrations. Gentamicin attains 30-40% of the plasma concentration in the bile, but persists for as long as 8 hours with excellent sensitivity and clinical efficacy. Amikacin reaches 44% of the plasma concentration with a very high sensitivity (96%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2502489

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  23 in total

1.  Differences in bile microbiology according to region and hospital: response to correspondence on "Bile microbiology at a hospital in southern Taiwan".

Authors:  W Kwon; S-W Kim; J-Y Jang
Journal:  Infection       Date:  2013-02-10       Impact factor: 3.553

2.  Diagnosis and management of acute cholangitis.

Authors:  Patrick Mosler
Journal:  Curr Gastroenterol Rep       Date:  2011-04

3.  Microbial profile and antibiotic sensitivity pattern in bile cultures from endoscopic retrograde cholangiography patients.

Authors:  Muhsin Kaya; Remzi Beştaş; Fatma Bacalan; Ferhat Bacaksız; Esma Gülsun Arslan; Mehmet Ali Kaplan
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

4.  Prospective observational multicenter study to define a diagnostic algorithm for biliary candidiasis.

Authors:  Philipp Lenz; Franziska Eckelskemper; Thomas Erichsen; Tim Lankisch; Alexander Dechêne; Gabriele Lubritz; Frank Lenze; Torsten Beyna; Hansjörg Ullerich; Andre Schmedt; Dirk Domagk
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

5.  What are the risk factors for acute suppurative cholangitis caused by common bile duct stones?

Authors:  Dong Han Yeom; Hyo Jeong Oh; Young Woo Son; Tae Hyeon Kim
Journal:  Gut Liver       Date:  2010-09-24       Impact factor: 4.519

6.  Risk factors of organ failure in cholangitis with bacteriobilia.

Authors:  Jae Min Lee; Sang Hyub Lee; Kwang Hyun Chung; Jin Myung Park; Ban Seok Lee; Woo Hyun Paik; Joo Kyung Park; Ji Kon Ryu; Yong-Tae Kim
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

7.  Permanent stenting in "unextractable" common bile duct stones in high risk patients. A prospective randomized study comparing two different stents.

Authors:  Franco Pisello; Girolamo Geraci; Francesco Li Volsi; Giuseppe Modica; Carmelo Sciumè
Journal:  Langenbecks Arch Surg       Date:  2008-08-05       Impact factor: 3.445

8.  Antimicrobial therapy for acute cholangitis: Tokyo Guidelines.

Authors:  Atsushi Tanaka; Tadahiro Takada; Yoshifumi Kawarada; Yuji Nimura; Masahiro Yoshida; Fumihiko Miura; Masahiko Hirota; Keita Wada; Toshihiko Mayumi; Harumi Gomi; Joseph S Solomkin; Steven M Strasberg; Henry A Pitt; Jacques Belghiti; Eduardo de Santibanes; Robert Padbury; Miin-Fu Chen; Giulio Belli; Chen-Guo Ker; Serafin C Hilvano; Sheung-Tat Fan; Kui-Hin Liau
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30

9.  Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines.

Authors:  Masahiro Yoshida; Tadahiro Takada; Yoshifumi Kawarada; Atsushi Tanaka; Yuji Nimura; Harumi Gomi; Masahiko Hirota; Fumihiko Miura; Keita Wada; Toshihiko Mayumi; Joseph S Solomkin; Steven Strasberg; Henry A Pitt; Jacques Belghiti; Eduardo de Santibanes; Sheung-Tat Fan; Miin-Fu Chen; Giulio Belli; Serafin C Hilvano; Sun-Whe Kim; Chen-Guo Ker
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-01-30

Review 10.  Biliary tract infections: a guide to drug treatment.

Authors:  J F Westphal; J M Brogard
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.